KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) FCF Margin (2016 - 2025)

Historic FCF Margin for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to 35.69%.

  • Medpace Holdings' FCF Margin rose 97100.0% to 35.69% in Q3 2025 from the same period last year, while for Sep 2025 it was 28.7%, marking a year-over-year increase of 28300.0%. This contributed to the annual value of 27.13% for FY2024, which is 61000.0% up from last year.
  • Latest data reveals that Medpace Holdings reported FCF Margin of 35.69% as of Q3 2025, which was up 97100.0% from 23.61% recorded in Q2 2025.
  • Medpace Holdings' 5-year FCF Margin high stood at 35.69% for Q3 2025, and its period low was 11.18% during Q1 2022.
  • For the 5-year period, Medpace Holdings' FCF Margin averaged around 23.58%, with its median value being 22.23% (2021).
  • Per our database at Business Quant, Medpace Holdings' FCF Margin plummeted by -176100bps in 2021 and then soared by 125400bps in 2024.
  • Over the past 5 years, Medpace Holdings' FCF Margin (Quarter) stood at 20.02% in 2021, then surged by 62bps to 32.34% in 2022, then decreased by -9bps to 29.38% in 2023, then rose by 16bps to 34.11% in 2024, then grew by 5bps to 35.69% in 2025.
  • Its FCF Margin stands at 35.69% for Q3 2025, versus 23.61% for Q2 2025 and 20.74% for Q1 2025.